GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) » Definitions » Debt-to-Revenue

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Debt-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is PT Industri Jamu dan Farmasi Sido Muncul Tbk Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp5,404 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was Rp3,300 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's annualized Revenue for the quarter that ended in Mar. 2024 was Rp4,213,692 Mil. PT Industri Jamu dan Farmasi Sido Muncul Tbk's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.00.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Debt-to-Revenue Historical Data

The historical data trend for PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Industri Jamu dan Farmasi Sido Muncul Tbk Debt-to-Revenue Chart

PT Industri Jamu dan Farmasi Sido Muncul Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PT Industri Jamu dan Farmasi Sido Muncul Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue falls into.



PT Industri Jamu dan Farmasi Sido Muncul Tbk Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(6091 + 3300) / 3565930
=0.00

PT Industri Jamu dan Farmasi Sido Muncul Tbk's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(5404 + 3300) / 4213692
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.


PT Industri Jamu dan Farmasi Sido Muncul Tbk Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of PT Industri Jamu dan Farmasi Sido Muncul Tbk's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Gajahmada No. 123, 1st Floor, Gedung Hotel Tentrem, Office Sido Muncul, Lantai 1, Semarang, IDN, 50134
PT Industri Jamu dan Farmasi Sido Muncul Tbk is biotechnology company that provides herbal medicine and pharmaceutical products. The company has three business segments, Herbal Medicine, Food and Beverage, and Pharmacy. The Herbal Medicine segment provides herbal supplements, while its Food and Beverage segment sells packaged foods, soft drinks, and candy and confectionary products. The Pharmacy segment sells pharmaceutical products such as Anacetine, a fever reducer, Berlosid, a medicine to reduce gastric pain, and Combicitrine, a medicine for bacterial removal. The company generates the majority of its revenue in Indonesia.

PT Industri Jamu dan Farmasi Sido Muncul Tbk (ISX:SIDO) Headlines

No Headlines